Jimenez FM, et al. Cholesterol lowering effect of a combination of red yeast rice and polycosanol. Revista de fitoterapia 2016;16(1):5-14.

Law MR, Wald NJ, Rudnicka AR. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. BMJ. 2003;326(7404):1423.

Liu J, et al. Chinese red yeast rice (Monascus purpureus) for primary hyperlipidemia: a meta-analysis of randomized controlled trials. Chin Med 2006;23;1:4.

Lin CC, et al. Efficacy and safety of Monascus purpureus Went rice in subjects with hyperlipidemia. Eur J Endocrinol 2005;153(5):679-86.

Yang CW, et al. The effect of red yeast rice (Monascus purpureus) in dyslipidemia and other disorders. Complement Ther Med 2012;20(6):466-74.

Glickman-Simon R, et al. Red Yeast Rice for High Cholesterol. Explore 2016;12(4):287-91.

Becker DJ, et al. Red yeast rice for dyslipidemia in statin-intolerant patients: a randomized trial. Ann Intern Med 2009;150(12):830-9.

Halbert SC, et al. Tolerability of red yeast rice (2400 mg twice daily) versus pravastatin (20 mg twice daily) in patients with previous statin intolerance. Am J Cardiol 2010;105(2):198-204.

Venero CV, et al. Lipid-lowering efficacy of red yeast rice in a population intolerant to statins. Am J Cardiol 2010;105(5):664-6.

Sartore G, et al. Mediterranean Diet and Red Yeast Rice Supplementation for the Management of Hyperlipidemia in Statin-Intolerant Patients with or without Type 2 Diabetes. Evid Based Complement Alternat Med 2013;2013:743473.

Hendler SS. Coenzyme Q10 (CoQ10). In: PDR for nutritional supplements, 2nd ed. New York: Thomson Reuters. p 151-5.

Skarlovnik A, et al. Coenzyme Q10 supplementation decreases statin-related mild-to-moderate muscle symptoms: a randomized clinical study. Med Sci Monit 2014;20:2183-8.

Cicero AF, et al. Middle-Term Dietary Supplementation with Red Yeast Rice Plus Coenzyme Q10 Improves Lipid Pattern, Endothelial Reactivity and Arterial Stiffness in Moderately Hypercholesterolemic Subjects. Ann Nutr Metab 2016;68(3):213-219.

Gong J, Quin X, Yuang F, Hu M, Chen G, Fang K. Efficacy and safety of sugarcane policosanol on dyslipidemia: a meta-analysis of randomized controlled trials. Molecular nutrition & Food research 2017.

Gouni-Berthold I, Berthold HK. Policosanol: clinical pharmacology and therapeutic significance of a new lipid-lowering agent. Am Heart J 2002;143(2):356-65.

Janikula M. Policosanol: a new treatment for cardiovascular disease? Alternative Medicine Review 2002;7(3):203-17.

Pons P, et al. Effects of successive dose increases of policosanol on the lipid profile of patients with type II hypercholesterolaemia and tolerability to treatment. Int J Clin Pharmacol Res 1994;14(1):27-33.

Castano G, et al. Effects of policosanol 20 versus 40 mg/day in the treatment of patients with type II hypercholesterolemia : A 6-month double-blind study. Int J Clin Pharmacol Res 2001;21(1):43-57.